DK2241196T4 - Næringsmiddelsupplement omfattende oligosaccharider og cystein til behandling af HIV - Google Patents

Næringsmiddelsupplement omfattende oligosaccharider og cystein til behandling af HIV Download PDF

Info

Publication number
DK2241196T4
DK2241196T4 DK10165389.7T DK10165389T DK2241196T4 DK 2241196 T4 DK2241196 T4 DK 2241196T4 DK 10165389 T DK10165389 T DK 10165389T DK 2241196 T4 DK2241196 T4 DK 2241196T4
Authority
DK
Denmark
Prior art keywords
cysteine
oligosaccharides
acid
oligosaccharide
composition
Prior art date
Application number
DK10165389.7T
Other languages
English (en)
Other versions
DK2241196T3 (da
Inventor
George Verlaan
Johan Garssen
Tol Eric Alexander Franciscus Van
Johannes Wilhelmus Christina Sijben
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34939442&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2241196(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Priority claimed from EP06733070.4A external-priority patent/EP1871181B2/en
Publication of DK2241196T3 publication Critical patent/DK2241196T3/da
Application granted granted Critical
Publication of DK2241196T4 publication Critical patent/DK2241196T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Claims (8)

1. Anvendelse af én eller flere sure og neutrale oligosaccharider og cystein og/eller cysteinkilde, i fremstillingen af en sammensætning til behandlingen af HIV eller AIDS hos et pattedyr, hvilken sammensætning omfatter en terapeutisk effektiv mængde sure og neutrale oligosaccharider, hvor de sure oligosaccharider fremstilles fra pektin, pektat, alginat, chondroitin, hyaluronsyrer, heparin, heparan, sialoglycaner, fucoidan, fucooligosaccharider eller carrageenan og det neutrale oligosaccharid er valgt fra gruppen bestående af galactooligosaccharid, fructooligosaccharid, transgalactooligo-saccharid, xylooligo-saccharid, lactosucrose og arabinooligosaccharider og hvor cysteinkilden er valgt blandt N-acetylcystein, valle, kolostrum, æggeproteiner eller en kombination deraf, og hvor cysteinet og/eller kilde af cystein tilvejebringer 100 mg cysteinækvivalent i en daglig dosis.2. Anvendelse ifølge det foregående krav, hvor cystein og/eller kilde af cystein tilvejebringer mindst 600, fortrinsvis mindst 1000 mg, cysteinækvivalent i en daglig dosis
3.. Anvendelse ifølge et hvilket som helst af de foregående krav, hvor de sure oligosaccharider er pektinhydrolysat.
4. Anvendelse ifølge et hvilket som helst af de foregående krav, hvor de neutrale oligosaccharider er en blanding af fructooligosaccharid og galactooligo-saccharid.
5.. Anvendelse ifølge et hvilket som helst af de foregående krav, hvor mindst 15% af de totale oligosaccharider omfatter sure oligosaccharider.
6. Anvendelse ifølge et hvilket som helst af de foregående krav, hvor sammensætningen yderligere omfatter polyumættede fedtsyrer (PUFA).
7. Sammensætning til anvendelse ifølge krav 6, hvor PUFA omfatter mindst 20% GLA plus EPA, baseret på det totale fedtsyreindhold.
8. Fødevaresammensætning omfattende mellem 15 og 50 en% lipid, mellem 25 og 60 en% protein, mellem 15 og 45 en% carbohydrat, sur oligosaccharid fremstillet fra pektin, pektat, alginat, chondroitin, hyaluronsyrer, heparin, heparan, sialoglycaner, fucoidan, fucooligosaccharider eller carrageenan, fortrinsvis pektinhydrolysat og neutrale oligosaccharider valgt fra gruppen bestående af galactooligosaccharid, fructooligosaccharid, transgalactooligosaccharid, xylooligo-saccharid, lactosucrose og arabinooligosaccharider og cystein og/eller en cysteinkilde valgt fra N-acetylcystein, valle, kolostrum, æggeproteiner eller en kombination deraf, og hvor cysteinet og/eller kilde af cystein omfatter mindst 25 en% af en fedtblanding omfattende n-3- og n-6-fedtsyrer.
9. Fødevaresammensætning omfattende mellem 15 og 50 en% lipid, mellem 35 og 60 en% protein, mellem 15 og 45 en% carbohydrat, sur oligosaccharid fremstillet fra pektin, pektat, alginat, chondroitin, hyaluronsyrer, heparin, heparan, sialoglycaner, fucoidan, fucooligosaccharider eller carrageenan, fortrinsvis pektinhydrolysat og neutral oligosaccharid valgt fra gruppen bestående af galactooligosaccharid, fructooligosaccharid, transgalactooligosaccharid, xylooligo-saccharid, lactosucrose og arabinooligosaccharider, og cystein og/eller cysteinkilde valgt fra N-acetylcystein, valle, kolostrum, æggeproteiner eller kombinationer deraf, hvor sammensætningen omfatter mindst 25 en% af en fedtblanding omfattende n-3- og n-6-fedtsyrer
DK10165389.7T 2005-04-21 2006-04-19 Næringsmiddelsupplement omfattende oligosaccharider og cystein til behandling af HIV DK2241196T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67334105P 2005-04-21 2005-04-21
EP05103257A EP1723951A1 (en) 2005-04-21 2005-04-21 Nutritional supplement with oligosaccharides for a category of HIV patients
EP06733070.4A EP1871181B2 (en) 2005-04-21 2006-04-19 Nutritional supplement for hiv patients

Publications (2)

Publication Number Publication Date
DK2241196T3 DK2241196T3 (da) 2012-09-10
DK2241196T4 true DK2241196T4 (da) 2017-07-24

Family

ID=34939442

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06733070.4T DK1871181T3 (da) 2005-04-21 2006-04-19 Kosttilskud til HIV-patienter
DK10165389.7T DK2241196T4 (da) 2005-04-21 2006-04-19 Næringsmiddelsupplement omfattende oligosaccharider og cystein til behandling af HIV

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK06733070.4T DK1871181T3 (da) 2005-04-21 2006-04-19 Kosttilskud til HIV-patienter

Country Status (21)

Country Link
US (2) US20080138435A1 (da)
EP (3) EP1723951A1 (da)
JP (1) JP2008536914A (da)
CN (1) CN101198337A (da)
AR (2) AR054257A1 (da)
AT (1) ATE524189T1 (da)
AU (1) AU2005330749B2 (da)
BR (2) BRPI0520116A2 (da)
CA (1) CA2605414A1 (da)
DK (2) DK1871181T3 (da)
ES (2) ES2346904T5 (da)
IL (1) IL186811A0 (da)
MX (1) MX2007013090A (da)
NO (1) NO20075373L (da)
NZ (1) NZ562667A (da)
PL (1) PL2241196T5 (da)
PT (2) PT1871181E (da)
RU (1) RU2403048C2 (da)
SI (1) SI2241196T1 (da)
WO (1) WO2006112694A2 (da)
ZA (1) ZA200709058B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
DE60316576T2 (de) * 2002-08-30 2008-01-31 Campina B.V. Schäumender bestandteil und diesen bestandteil enthaltende produkte
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1721611A1 (en) * 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
PT1758469E (pt) * 2004-06-22 2010-02-03 Nutricia Nv Melhoria da integridade da barreira nos doentes com vih com o uso de ácidos gordos
DE602006015042D1 (de) * 2005-04-21 2010-08-05 Nutricia Nv Nahrungsergänzungsmittel für hiv-patienten
ATE509624T1 (de) * 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
EP2200443B2 (en) 2007-09-17 2021-06-30 Cornell University Branched chain fatty acids for prevention or treatment of gastrointestinal disorders
WO2009096772A1 (en) * 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
PT2643017T (pt) 2010-11-23 2019-09-05 Pantheryx Inc Composições e métodos para tratamento em aplicações clínicas de amplo espetro, misturadas ou indiferenciadas
BR112013019677B1 (pt) 2011-02-02 2019-10-08 Société des Produits Nestlé S.A. Uso de proteína compreendendo pelo menos 30% do total da energia da composição nutricional e de uma proporção de ácidos graxos ômega-6 e ômega-3
EP2696867A1 (en) * 2011-04-12 2014-02-19 Nestec S.A. Nutritional compositions including branched chain fatty acids for improving gut barrier function
MX352677B (es) 2011-06-20 2017-12-04 Heinz Co Brands H J Llc Composiciones probioticas y metodos.
WO2014100191A1 (en) * 2012-12-18 2014-06-26 Abbott Laboratories Nutritional compositions comprising neuroprotective dietary oligosaccharides
PT2994150T (pt) 2013-05-10 2019-06-14 Heinz Co Brands H J Llc Probióticos e métodos de utilização
WO2015058115A1 (en) * 2013-10-17 2015-04-23 University Of Georgia Research Foundation, Inc. Structured triacylglycerols and methods for making the same
US20170007559A1 (en) * 2015-07-12 2017-01-12 The University Of Tennessee Research Foundation Compositions and methods for protecting colonic epithelial barrier function
JP7136807B2 (ja) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981629A (en) * 1960-04-05 1961-04-25 Lewis F Ginnette Process of dehydrating foams
US4237118A (en) * 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
JPS5645951B2 (da) * 1973-05-21 1981-10-29
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4438147A (en) * 1982-06-25 1984-03-20 Societe D'assistance Technique Pour Produits Nestle S.A. Foaming creamer and method of making same
JPH01149730A (ja) * 1987-12-07 1989-06-12 Osaka Prefecture レトロウイルス増殖抑制剤
JP2782443B2 (ja) * 1988-12-26 1998-07-30 將純 吉原 抗エイズウィルス剤
ATE287415T1 (de) 1990-07-13 2005-02-15 Gropep Ltd Wachstumsfördernder wirkstoff
AU661297B2 (en) * 1991-01-24 1995-07-20 Martek Corporation Microbial oil mixtures and uses thereof
FR2673812B1 (fr) * 1991-03-13 1994-04-01 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
JPH04300888A (ja) * 1991-03-28 1992-10-23 Dainippon Ink & Chem Inc カルボン酸オリゴ糖エステル硫酸化物
US5629023A (en) * 1991-12-31 1997-05-13 Bland; Jeffrey S. Medical food composition for metabolic detoxification
US5502041A (en) * 1992-12-11 1996-03-26 The Center For Innovative Technology Potent inhibitor of HIV reverse transcriptase
US5472952A (en) * 1993-03-18 1995-12-05 Bristol-Myers Squibb Company Partially hydrolyzed pectin in nutritional compositions
NZ248603A (en) † 1993-05-28 1994-12-22 Abbott Lab Nutritional product for enteral nutritional support of hiv victims comprising proteins and fat
JP3310738B2 (ja) * 1993-11-10 2002-08-05 株式会社ロッテ 低カロリーチョコレート
DE4404877C1 (de) * 1994-02-17 1995-03-02 Ksk Industrielackierungen Gmbh Lackierverfahren und zur Durchführung des Verfahrens geeignete Lackgießvorrichtung
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5661123A (en) † 1995-01-17 1997-08-26 Nestec, Ltd. Enteral composition for malabsorbing patients
US5733579A (en) * 1995-04-05 1998-03-31 Abbott Laboratories Oral rehydration solution containing indigestible oligosaccharides
US20020016289A1 (en) * 1995-06-01 2002-02-07 Orla M. Conneely Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
ES2123903T5 (es) * 1995-08-04 2011-02-22 N.V. Nutricia Composición nutritiva conteniendo fibra.
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
GB9619660D0 (en) * 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
KR20000048855A (ko) * 1996-10-02 2000-07-25 오비뮨, 인크. 닭의 난황 항체를 경구 투여하여 질병을 치료하는 방법
PL185442B1 (pl) * 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie
JPH10108647A (ja) * 1996-10-08 1998-04-28 Meiji Seika Kaisha Ltd 胃切除術後患者用ミネラル補給材
JP4008974B2 (ja) * 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US5840361A (en) * 1997-04-09 1998-11-24 Beech-Nut Nutrition Corporation Fructan-containing baby food compositions and methods therefor
NL1005809C2 (nl) * 1997-04-14 1998-10-19 Dsm Nv Poederverfbindmiddelsamenstelling.
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
US6051260A (en) * 1998-04-07 2000-04-18 Healthcomm International, Inc. Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity
AUPP327198A0 (en) * 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
US6667063B2 (en) † 1998-06-10 2003-12-23 Albert Crum Nutritional or therapeutic supplement and method
WO1999064022A1 (en) † 1998-06-10 1999-12-16 Crum Albert B Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
US6794495B1 (en) * 1998-10-19 2004-09-21 New Nordic Danmark Aps Composition comprising extensin and, optionally, pectic polysaccharides
HU229885B1 (en) * 1999-01-28 2014-11-28 Nestle Sa Aromatised soluble creamer powder
EP1074181A1 (en) * 1999-08-03 2001-02-07 Societe Des Produits Nestle S.A. Foaming creamer ingredient and powders containing it
US6737089B2 (en) * 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
DE10006989A1 (de) * 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
US6846501B2 (en) * 2000-04-12 2005-01-25 Mid-America Commercialization Corporation Traditional snacks having balanced nutritional profiles
US6426110B1 (en) * 2000-08-11 2002-07-30 Global Health Sciences, Inc. Low-carbohydrate high-protein creamer powder
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
CN1111541C (zh) * 2000-09-15 2003-06-18 青岛海洋大学 一种聚甘露糖醛酸硫酸盐
ATE328491T1 (de) 2000-10-24 2006-06-15 Campina Melkunie Bv Peptiden reich an cystein und/oder glycin
DE10057976B4 (de) * 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
CN1457357A (zh) * 2001-02-15 2003-11-19 旭电化工业株式会社 包含β－葡聚糖的制品
US20040102377A1 (en) 2001-04-10 2004-05-27 Irene Perrin Method and composition for prophylaxis of diabetes
WO2004000042A2 (en) * 2002-06-19 2003-12-31 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
DE60316576T2 (de) * 2002-08-30 2008-01-31 Campina B.V. Schäumender bestandteil und diesen bestandteil enthaltende produkte
US20040122105A1 (en) * 2002-09-20 2004-06-24 Griscom Bettle Transdermal compositions
US6974841B1 (en) * 2002-09-27 2005-12-13 Rapisarda Family Irrevocable Trust Pet anti-aging wellness supplement
US20040077590A1 (en) † 2002-10-22 2004-04-22 Leach James L. Use of soluble monovalent oligosaccharides as inhibitors of HIV-1 fusion and replication
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
WO2004112508A1 (en) * 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula
AU2003904192A0 (en) * 2003-08-11 2003-08-21 Adelaide Research and Innovaiton Pty Ltd Method for inhibiting bacterial colonisation
JP4943853B2 (ja) * 2003-10-24 2012-05-30 エヌ．ブイ．・ヌートリシア 免疫調節性オリゴ糖
FR2866203B1 (fr) * 2004-02-13 2006-12-08 Roquette Freres Procede de fabrication d'un produit de cuisson a base de gluten
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) † 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1721611A1 (en) * 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
PT1758469E (pt) * 2004-06-22 2010-02-03 Nutricia Nv Melhoria da integridade da barreira nos doentes com vih com o uso de ácidos gordos
EP1634599A1 (en) * 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
DE602006015042D1 (de) * 2005-04-21 2010-08-05 Nutricia Nv Nahrungsergänzungsmittel für hiv-patienten
WO2007015932A1 (en) * 2005-07-27 2007-02-08 Cantabria Group Lcc Phosphorylated glucomannane polysaccharides containing 1-6 and 1-2 linkages increase weight gain in poultry
WO2009096772A1 (en) * 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity

Also Published As

Publication number Publication date
AR054257A1 (es) 2007-06-13
PL2241196T5 (pl) 2017-10-31
EP2241196B2 (en) 2017-04-05
AU2005330749A1 (en) 2006-10-26
RU2007143059A (ru) 2009-05-27
WO2006112694A2 (en) 2006-10-26
CA2605414A1 (en) 2006-10-26
BRPI0610786A2 (pt) 2010-11-09
AR054255A1 (es) 2007-06-13
PT2241196E (pt) 2012-12-06
ES2392940T3 (es) 2012-12-17
BRPI0610786B1 (pt) 2018-11-13
AU2005330749B2 (en) 2011-08-04
WO2006112694A8 (en) 2007-12-27
ATE524189T1 (de) 2011-09-15
NZ562667A (en) 2009-06-26
BRPI0610786B8 (pt) 2021-05-25
EP2241196A2 (en) 2010-10-20
DK2241196T3 (da) 2012-09-10
US20110236500A1 (en) 2011-09-29
CN101198337A (zh) 2008-06-11
NO20075373L (no) 2008-01-18
DK1871181T3 (da) 2010-09-27
EP1723951A1 (en) 2006-11-22
EP2241196A3 (en) 2010-11-17
EP2241196B1 (en) 2012-08-22
PT1871181E (pt) 2010-09-21
ES2392940T5 (es) 2017-07-28
RU2403048C2 (ru) 2010-11-10
IL186811A0 (en) 2008-02-09
ES2346904T3 (es) 2010-10-21
WO2006112694A3 (en) 2007-01-18
MX2007013090A (es) 2008-01-11
US20080138435A1 (en) 2008-06-12
BRPI0520116A2 (pt) 2009-09-15
PL2241196T3 (pl) 2013-01-31
EP1890707A2 (en) 2008-02-27
SI2241196T1 (sl) 2012-12-31
JP2008536914A (ja) 2008-09-11
EP1890707B1 (en) 2011-09-14
ZA200709058B (en) 2008-11-26
ES2346904T5 (es) 2017-06-09

Similar Documents

Publication Publication Date Title
DK2241196T4 (da) Næringsmiddelsupplement omfattende oligosaccharider og cystein til behandling af HIV
AU2006237738B2 (en) Nutritional supplement for HIV patients
US20090082249A1 (en) Nutritional supplement for a category of hiv patients
US11135290B2 (en) Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
WO2008156354A1 (en) Modulation of intestinal flora of hiv patients